Bush's nominee for FDA Commissioner supports OTC sales of Plan B (RU-486) for women over 18 years of age. Girls under 18 would still need a prescription.
"FDA does not have the enforcement authority to ensure that store clerks are checking age ID for dual status drugs. Given FDA's track record with RU-486, it is difficult to see how they will enforce a strict distribution agreement with Plan B," the FRC stated.
"Recognizing the importance of the health of women and the role the FDA plays in protecting that health, Family Research Council cannot in good conscience support the confirmation of Dr. von Eschenbach as FDA Commissioner," the statement added.